Suspect Sought in an Assault with Intent to Commit Robbery while Armed (Knife): 1400 Block of Pennsylvania Avenue, Southeast

Detectives from the Metropolitan Police Department’s First District seek the public’s assistance in locating a suspect in reference to an Assault with Intent to Commit Robbery while Armed (Knife) offense that occurred on Friday, September 17, 2021, in the 1400 block of Pennsylvania Avenue, Southeast.

 

At approximately 11:13 pm, the suspect approached the victim at the listed location. The suspect brandished a knife and demanded the victim’s property. The victim fled into a nearby establishment. The suspect fled the scene without obtaining any property from the victim.

 

The suspect was captured by a surveillance camera and can be seen in this video: https://youtu.be/Pw_OC37Q2pY

 

Anyone who can identify this individual or has knowledge of this incident should take no action but call police at (202) 727-9099 or text your tip to the Department’s TEXT TIP LINE at 50411. The Metropolitan Police Department currently offers a reward of up to $1,000 to anyone who provides information that leads to the arrest and conviction of the person or persons responsible for a violent crime committed in the District of Columbia.

 


Source: EIN Presswire

THE DAILY LEADER: TUESDAY, SEPTEMBER 21, 2021

“One Minutes” (15 per side) at 12:00 p.m.

H.R. __ – An act making continuing appropriations for the fiscal year ending September 30, 2022, and for providing emergency assistance, and for other purposes (Rep. DeLauro – Appropriations) (Subject to a Rule)

Possible Passage of Postponed Suspensions (10 votes)

  1. S. 848 – Consider Teachers Act of 2021 (Sen. Braun – Education and Labor)
  2. S. 1828 – HAVANA Act of 2021 (Sen. Collins – Foreign Affairs)
  3. H.R. 1029 – Free Veterans from Fees Act (Rep. Steube – Natural Resources)
  4. H.R. 1154 – Great Dismal Swamp National Heritage Area Act (Rep. McEachin – Natural Resources)
  5. H.R. 3533 – To establish occupational series for Federal positions in software development, software engineering, data science, and data management, and for other purposes, as amended (Rep. Obernolte – Oversight and Reform)
  6. H.R. 3599 – Federal Rotational Cyber Workforce Program Act of 2021, as amended (Rep. Khanna – Oversight and Reform)
  7. H.R. 1204 – District of Columbia Chief Financial Officer Salary Home Rule Act, as amended (Rep. Norton – Oversight and Reform)
  8. H.R. 978 – Chai Suthammanont Remembrance Act of 2021, as amended (Rep. Connolly – Oversight and Reform)
  9. H.R. 2617 – Performance Enhancement Reform Act, as amended (Rep. Connolly – Oversight and Reform)
  10. S. 2382 – To authorize the National Cyber Director to accept details from other elements of the Federal Government on nonreimbursable basis, and for other purposes (Sen. Portman – Oversight and Reform)

Possible Consideration of Suspensions (5 bills)

  1. H.R. 4611 – DHS Software Supply Chain Risk Management Act of 2021, as amended (Rep. Torres (NY) – Homeland Security)
  2. H.R. 4089 – Darren Drake Act, as amended (Rep. Gottheimer – Homeland Security)
  3. S. 1917 – K-12 Cybersecurity Act of 2021 (Sen. Peters – Homeland Security)
  4. H.R. 4094 – One-Stop Pilot Program Act of 2021, as amended (Rep. Katko – Homeland Security)
  5. H.R. 4682 – UAS Act, as amended (Rep. Guest – Homeland Security)

Begin Consideration of H.R. 4350 – National Defense Authorization Act for Fiscal Year 2022 (Rep. Smith (WA) – Armed Services) (Subject to a Rule)

Members are advised that following last votes the House is expected to begin debate on H.R. 4350.  The House will complete consideration of the bill later in the week.

 


Source: EIN Presswire

Oʻahu selected for federal pilot program to provide one million free at-home COVID-19 tests

Posted on Sep 20, 2021 in COVID-19, Newsroom

Oʻahu residents in eligible ZIP codes can order free COVID-19 test kits while supplies last at COVIDTestHonolulu.org

HONOLULU – Oʻahu was selected for a federal pilot program that will provide free at-home COVID-19 test kits to eligible residents.

The Say Yes! COVID Test At-Home Testing Challenge will provide 125,000 Oʻahu residents who live in eligible ZIP codes with eight rapid antigen tests. The program encourages participants to use the tests twice a week for four weeks, regardless of symptoms, to reduce the spread of COVID-19 and keep the community healthy.

“Free, rapid, self-administered testing will give community members one more way to help reduce the spread of COVID-19,” said Health Director Dr. Elizabeth Char, FACEP. “This program provides participating communities with another tool to protect themselves and their families as we continue to increase access to testing.”

Residents of the following zip codes are eligible for the program: 96701, 96706, 96707, 96712, 96717, 96730, 96731, 96734, 96744, 96762, 96782, 96786, 96789, 96791, 96792, 96795, 96797, 96813, 96814, 96815, 96816, 96817, 96818, 96819, 96821, 96822, 96825, 96826, 96844, 96850, 96853, 96854, 96857, 96858, 96859, 96860, 96861, 96863.

Individuals who have not yet received the COVID-19 vaccine or who have the highest risk of exposure to COVID-19, such as people working or going to school outside the home, are ideal candidates for participation, but anyone over the age of two is welcome to participate.

Oʻahu residents in participating communities can order test kits through COVIDTestHonolulu.org for home delivery. Test kits will also be available through community organizations. A free online tool that also is available as a phone app will be offered to provide testing instructions, information to help understand test results, and text message reminders about testing. Data is stored securely and no DNA or specimen is collected.

Test kits will be available through Oct. 18, or while supplies last. The self-administered tests cannot be used for workplace testing requirements or other programs that require documented testing.

Community engagement efforts are underway to ensure that underserved populations and those without internet access can participate in the program. Community organizations interested in serving as a distribution partner should contact [email protected].

Individuals may elect to share their test results with DOH. Those who test positive on self-administered tests should follow home isolation guidelines and contact their healthcare provider to seek follow-up testing.

The Say Yes! COVID Test initiative is a cooperative effort between DOH, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), community partners, test manufacturer Quidel, and healthcare technology company CareEvolution. Researchers at NIH-supported academic health centers will work with CDC and NIH to use publicly available data to determine if the local testing efforts slowed the spread of COVID-19.

Rapid, self-administered testing has potential to disrupt the spread of COVID-19 that occurs when people are infected, but don’t yet have symptoms. Testing twice a week increases chances of identifying COVID-19 infection and isolating early.

The rapid antigen COVID-19 tests are authorized for use by the Food and Drug Administration and are provided free of charge. Tests require a quick swab inside each nostril. Results can be read in about 10 minutes. A free, private, and easy-to-use mobile application is available to help individuals in every step of test taking. Each test package (four kits; eight tests total) supports home testing twice a week for four weeks for an individual.

# # #

PDF: Oʻahu selected for federal pilot program to provide one million free at-home COVID-19 tests


Source: EIN Presswire

Attorney General Josh Stein Calls for Stronger Federal Antitrust Protections

For Immediate Release:

Monday, September 20, 2021

Contact:

Nazneen Ahmed (919) 716-0060

(RALEIGH) Attorney General Josh Stein today urged federal lawmakers to strengthen and improve several pieces of legislation currently in Congress that would modernize federal antitrust laws.

“I’m grateful to Congress for taking a close look at our antitrust laws and working to improve them to better protect consumers,” said Attorney General Stein. “No company in any industry should get so powerful or so big that they harm competition and innovation, and ultimately, consumers. I urge Congress to finish the job on these important bills.”

Attorney General Stein joined a coalition of 32 attorneys general in a letter recommending provisions that would facilitate competition and innovation and would further protect consumers from unlawful and irresponsible mergers and business practices. The attorneys general note that these changes are necessary as a result of technological innovations, less competition in important business sectors, and undue judicial skepticism towards robust antitrust enforcement.

Further, the attorneys general urge Congress to include language that would confirm that states and the federal government can equally enforce federal antitrust law and challenge anticompetitive mergers and other business practices.

Antitrust-related bills moving through Congress include continued consideration of the Ending Platform Monopolies Act, the American Choice and Innovation Online Act, the Platform Competition and Opportunity Act, the Augmenting Compatibility and Competition by Enabling Service Switching (“ACCESS”) Act, the Merger Filing Fee Modernization Act, and the State Antitrust Enforcement Venue Act.

Attorney General Stein was joined in sending today’s letter by the Attorneys General of Colorado, Nebraska, New York, Tennessee, California, Connecticut, Delaware, the District of Columbia, Guam, Hawaii, Idaho, Illinois, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Pennsylvania, Rhode Island, Utah, Vermont, Virginia, Washington, and Wisconsin.

A copy of the brief is available here.

###


Source: EIN Presswire

Upcoming Public Meetings This Week and Next on the Climate Action Plan

The Department of Public Service is coordinating with the Vermont Climate Council on a series of public meetings in September. Comments from participants can inform both the Climate Action Plan (CAP) under development by the Climate Council and the Comprehensive Energy Plan (CEP) being developed by the PSD. In August 2021, the PSD coordinated with the Climate Council on a series of Technical Workshops focused on electricity, buildings/thermal sector, and transportation.   

Please join the Vermont Climate Council by participating in one of the upcoming public meetings either online or in person. All events are family friendly, free, and open to everyone interested in attending. Food will be provided at all in-person events. In addition, interpretation services may be made available for individuals who register in advance. Please note that in-person events are being held in outdoor pavilions or shelters and will observe COVID-19 safety protocols. All participants in attendance will be asked to wear masks.

Meeting dates, times. and locations are as follows: 

For more information about the meetings, to RSVP, and to attend online, please visit the Department’s 2022 Comprehensive Energy Plan webpage or the Vermont Climate Council’s Get Involved webpage. 


Source: EIN Presswire

Governor Mills Proclaims September 20-24 as Clean Energy Week in Maine

Governor Janet Mills has proclaimed (PDF) this week – September 20, 2021 through September 24, 2021 – as Clean Energy Week in Maine. Clean Energy Week recognizes the critical need to develop clean, renewable energy to contribute to the global efforts against climate change, offset the use of imported fossil fuels, and build a thriving economy with good-paying jobs across Maine. 

“Transitioning to clean energy will not only fight climate change, it will create good-paying jobs, support our economic recovery from the pandemic, and make our state competitive in emerging industries around the world,” said Governor Janet Mills. “We will continue our work to make Maine a global leader in clean energy by investing in research and development, expanding workforce training, and attracting innovation. During Clean Energy Week, I encourage the people of Maine to join me in recognizing the importance of clean energy as we chart our future.”

Governor Mills has taken steps to embrace clean energy and prepare for and mitigate the effects of climate change on Maine. Maine has set some of the most aggressive renewable energy requirements in the country – 80 percent renewable energy by 2030, and a goal of 100 percent by 2050. Maine also enacted aggressive targets to cut greenhouse gas emissions – 45 percent by 2030, and 80 percent by 2050, as well as achieving carbon neutrality by 2045. Governor Mills has also pledged to more than double Maine’s clean energy and energy efficiency jobs to 30,000 by 2030; to expand incentives for purchasing electric vehicles (EV) and build more EV charging stations across Maine; to double the pace of home weatherization; and to purchase more renewable energy through the state procurement process. More information about the Governor’s actions to mitigate climate change can be found here on the Maine Climate Council’s website.

The text of the Governor’s proclamation is below:

WHEREAS, Maine is committed to a clean energy future and enjoys abundant forms of renewable energy that powers homes and businesses across the State; and

WHEREAS, the generation of power from renewable sources, including forms such as hydro, wood, wind, and solar, plays an important role in meeting the needs of our homes and businesses; and

WHEREAS, Maine has a Renewable Portfolio Standard that requires 80 percent renewable energy by 2030 and has a goal of 100 percent by 2050; and

WHEREAS, Maine leads New England in wind-powered generation; and

WHEREAS, the American Council for an Energy-Efficient Economy ranked Maine 16th in its 2020 State Energy Efficiency Scorecard; and

WHEREAS, Maine supports the strategic electrification of heating and transportation, establishing the goal of installing 100,000 new heat pumps by 2025, as well as leading initiatives to expand availability of electric vehicles and charging infrastructure; and

WHEREAS, recognizing the urgency of taking action to combat climate change, Maine has established mandates to reduce greenhouse gas emissions 45 percent below 1990 levels by 2030 and at least 80 percent by 2050 and created the Maine Climate Council that released the Maine Climate Action Plan that provides recommendations to meet these targets; and

WHEREAS, clean energy is part of America’s energy future and includes generation from renewable sources such as onshore wind, offshore wind, solar, hydro and geothermal sources, as well as energy storage; and

WHEREAS, the clean energy sector is an expanding part of the economy and has been a key driver of growth in Maine over the last decade, and Maine has a goal of more than doubling the clean energy workforce in the state to 30,000 jobs by 2030, growing local economies and boosting the state’s workforce and economic development;

NOW, THEREFORE, be it resolved that I, Janet T. Mills, Governor of the State of Maine, do hereby proclaim September 20th through September 24th, 2021 as

NATIONAL CLEAN ENERGY WEEK

throughout the State of Maine, and I urge all citizens to recognize this observance.

In testimony whereof, I have caused

the Great Seal of the State to be

hereunto affixed GIVEN under my

hand at Augusta this twentieth day of

September Two Thousand Twenty-One

Janet T. Mills

Governor


Source: EIN Presswire

Jose Eshkenazi Smeke: La campaña de publicidad con Alexa Moreno un acierto de marketing deportivo.

Jose Eshkenazi Publicidad en canchas de futbol

Jose Eshkenazi Publicidad en canchas de futbol

Jose Eshkenazi Publicidad en canchas de futbol

Jose Eshkenazi Publicidad en canchas de futbol

Jose Eshkenazi de Soccer Media Solutions explica publicidad deportiva las olimpiadas

Jose Eshkenazi Publicidad en canchas de futbol

Jose Eshkenazi Smeke reconoce que la posibilidad de premiar a los cuartos lugares de las olimpiadas podrías ser benéfico para el impulso de diversas disciplinas

Un gran ejemplo es el comercial de Toyota estelarizado por Alexa Moreno, primera mexicana en ganar medalla en un campeonato mundial. Vincular a los atletas a estas campañas fortalece al deporte”

— Jose Eshkenazi Smeke

MIAMI, FLORIDA, ESTADOS UNIDOS, September 21, 2021 /EINPresswire.com/ —
El experto en marketing deportivo Jose Eshkenazi Smeke señaló que: “No solo se debe dar difusión al cuadro de medallas si no que se requiere mayor difusión a todos los diplomas que se otorgan por cada competencia. La gran mayoría de los sitios de difusión de las olimpiadas carecen de información sobre los ganadores de 4to a octavo lugar en las Olimpiadas. Es muy relevante para apoyar al desarrollo del deporte una mayor inclusión en las competencias olímpicas, que se haga un mayor reconocimiento a los ganadores de diploma de 4to a 8vo lugar.” Si bien los datos expuestos por la BBC realizados por Nielsen muestran sobre los cuartos lugares en las Olimpiadas de Tokio señalan que EUA es el país con mayor número de cuartos lugares y el espectro de países aumenta con Corea del Sur 12, Canadá 11, Países Bajos 11 que serían altamente beneficiados, así como otras naciones como México con 7. Ciertamente en el único cuadro de honor que hoy no quieres estar es en El del Cuarto Lugar, el cuál a menudo se considera como la "peor posición para terminar", fuera de las medallas y frecuentemente con el más mínimo de diferencia, lo suficiente como para separar el éxtasis y la angustia.
Se repartieron 339 medallas en los juegos olímpicos de Tokio 2020, eso indica que hay 339 atletas que quedaron en 4to lugar y aproximadamente 1695 Atletas de 11,711 inscritos podrían recibir un mayor reconocimiento. Sin duda ayudaría la promoción del deporte a nivel mundial.
Así mismo Jose Eshkenazi Smeke, experto en marketing asociado a Fútbol Soccer, destaco que: “un gran ejemplo, es el equipo brasileño de natación en los juegos olímpicos de Tokio 2020 quienes tuvieron un extraordinario desempeño y a mi parecer les falto un reconocimiento mayor. Esta falta de reconocimiento podría provocar que para el próximo ciclo olímpico quizá no se tuvieran los recursos suficientes para que Brasil pudiera mejor o mantener su nivel de competencia en esta categoría”.
De igual forma el ejecutivo líder en Publicidad Virtual en eventos deportivos resalta: “Un gran ejemplo en ese sentido es el comercial de Toyota estelarizado por Alexa Moreno, Gimnasta Mexicana 4to lugar en Olimpiada Tokio 2020 y primera mexicana en ganar medalla en un campeonato mundial de gimnasia. Vincular a los atletas a estas campañas fortalece al deporte y genera un mensaje positivo hacia la sociedad”.
Jose Eshkenazi fue enfático en señalar lo siguiente: “Si no se desarrollan con mayor difusión los reconocimientos a las actividades en los juegos olímpicos será más complicado captar mayores recursos públicos, así como publicitarios. Administrar los recursos en función de sólo generar ganadores de primer, segundo y tercer lugar va a generar que los países sólo se enfoquen en deportes en donde las grandes potencias no les es relevante. La visión de desarrollo de deporte debe ser lo más amplia posible, parecida a la difusión y branding positivo que generan los actores nominados a un Oscar,por ejemplo.
Finalmente, el ejecutivo se refirió a la ya conocida Propuesta Jose Eshkenazi: “Las olimpiadas de verano deberían de realizarse cada dos años. Faltan más eventos de gran impacto en estas categorías. En el caso del futbol dependerá de un acuerdo entre los clubes y la FIFA. Pero en el tema de las olimpiadas parece que sería muy afortunado bajo la regla que se permita aprovechar la infraestructura existente para juegos olímpicos, es decir, que un país organice los juegos olímpicos de forma consecutiva si se realizan cada dos años. Los números hacen pensar que es posible lograr la rentabilidad económica para las inversiones en infraestructura creadas para la celebración de las olimpiadas.”
Jose Eshkenazi Smeke es un destacado líder en marketing deportivo enfocado a Fútbol Soccer. Ha creado importantes empresas en esta categoría apoyado por el uso de tecnología. Asimismo, se destaca por su actividad filantrópica y de integración al deporte en diversas comunidades.

Roberto Lopez
SenderoMoreno Inc
email us here

Publicidadencanchasdefutbol.com presenta el nuevo podcast de Jose Eshkenazi Smeke


Source: EIN Presswire

Advanced Ovarian Cancer Pipeline Report: Current Therapies, Emerging Drugs, and Treatment Outlook | DelveInsight

There are approximately 50+ key companies that are developing therapies for Advanced Ovarian Cancer. The drug candidates of ImmunoGen and OncoQuest Inc. are in the most advanced stage (Phase III). The Advanced Ovarian Cancer pipeline appears robust due to its prevalence and increasing demand for effective therapies.

Los Angeles, USA, Sept. 20, 2021 (GLOBE NEWSWIRE) — Advanced Ovarian Cancer Pipeline Report: Current Therapies, Emerging Drugs, and Treatment Outlook | DelveInsight

There are approximately 50+ key companies that are developing therapies for Advanced Ovarian Cancer. The drug candidates of ImmunoGen and OncoQuest Inc. are in the most advanced stage (Phase III). The Advanced Ovarian Cancer pipeline appears robust due to its prevalence and increasing demand for effective therapies.

DelveInsight’s “Advanced Ovarian Cancer Pipeline Insight” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Ovarian Cancer pipeline landscapes. It comprises Advanced Ovarian Cancer pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Advanced Ovarian Cancer therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Advanced Ovarian Cancer pipeline products.     

Some of the key takeaways from the Advanced Ovarian Cancer Pipeline Report  

  • Major companies such as ImmunoGen, OncoQuest, Lee’s Pharmaceutical, Allarity Therapeutics, AstraZeneca, Jiangxi Qingfeng Pharmaceutical Co. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Ellipses Pharma, Merck KGaA, Pfizer, Jiangsu HengRui Medicine Co., Ltd., Boehringer Ingelheim, Impact Therapeutics, Inc., Glycotope, Puma Biotechnology, Inc., MaxCyte, Inc., Bayer, Xennials Therapeutics, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daiichi Sankyo, Inc., Astellas Pharma Inc, and others are developing potential drug candidates to improve the Advanced Ovarian Cancer treatment scenario. 
  • The US Food and Drug Administration (FDA) granted orphan drug designation to mirvetuximab to treat ovarian cancer; mirvetuximab has also secured this designation in the EU. 
  • In June 2018, the FDA granted mirvetuximab Fast Track designation to treat patients with a medium to high FRα-positive platinum-resistant ovarian cancer who got administered at least one but no more than three prior systemic treatment regimens for whom single-agent chemotherapy is apt as the following line of therapy. 
  • In August 2021, Sutro Biopharma received Fast Track Designation for STRO-002 by the US FDA for Patients with Advanced Ovarian Cancer.
  • In February 2021, the FDA granted a fast-track designation to the DNA-mediated interleukin-12 immunotherapy GEN-1 to treat advanced ovarian cancer patients. Developed using Celsion’s exclusive TheraPlas platform technology, GEN-1 is an IL-12 DNA plasmid vector enclosed in a nanoparticle delivery system, which allows cell transformation followed by persistent, local emission of the IL-12 protein.
  • In April 2021, Zentalis Pharmaceuticals announced a clinical collaboration agreement to evaluate its ZN-c3 and GlaxoSmithKline’s (GSK) ZEJULA (niraparib) combination advanced epithelial ovarian cancer patients.
  • Stenoparib (2X-121), a unique, small molecule dual-targeted inhibitor of Poly ADP-Ribose Polymerases (PARP 1 and 2) and telomerase maintenance enzymes (Tankyrase 1 and 2), was exclusively in-licensed by Allarity Therapeutics (globally) from Eisai and is currently being evaluated in Phase II clinical trial for advanced ovarian cancer.
  • In January 2020, Mereo BioPharma Group and Oncologie entered a global licensing agreement to develop and commercial navicixizumab. Navicixizumab is an anti-DLL4/vascular endothelial growth factor (VEGF) bispecific antibody that is currently being evaluated, in combination with paclitaxel, for the treatment of patients with advanced heavily pretreated ovarian cancer. FDA granted fast track designation to navicixizumab in October 2019.

Get an overview of pipeline landscape @ Advanced Ovarian Cancer Clinical Trials Analysis 

Advanced Ovarian Cancer is cancer that has spread outside the ovary. It may have spread within the pelvis or abdomen or further away to other parts of the body, such as the lungs. 

Advanced Ovarian Cancer Emerging Drugs

  • Mirvetuximab soravtansine (IMGN853): ImmunoGen

Mirvetuximab soravtansine (IMGN853) is a first-in-class ADC comprising a folate receptor alpha (FRα)-binding antibody, cleavable linker, and the maytansinoid payload DM4, a potent tubulin-targeting agent to eliminate the targeted cancer cells. The drug is currently being assessed in the Phase III stage of development for the treatment of advanced ovarian cancer.

  • Oregovomab: OncoQuest

OncoQuest‘s lead product candidate is oregovomab, an anti-CA-125 antibody for treating ovarian cancer, which has met a Phase 2 frontline randomized controlled study. The company is conducting a Phase 3, Double-Blind, Placebo-Controlled, and Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel – Carboplatin – Oregovomab versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) In Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma (FLORA-5/GOG-3035).

  • IMP4297: IMPACT Therapeutics

IMP4297 is a novel agent targeting PARP developed by IMPACT therapeutics. The company has started a randomized, placebo-controlled, double-blinded, multi-center, phase III clinical study in China to assess the efficacy and safety of IMP4297 as the maintenance treatment in advanced ovarian cancer patients after first-line platinum-containing chemotherapy.

  • Stenoparib: Allarity therapeutics

Stenoparib (2X-121) is a unique, small molecule dual-targeted inhibitor of Poly ADP-Ribose Polymerases (PARP 1 and 2) and telomerase maintenance enzymes (Tankyrase 1 and 2). Allarity exclusively in-licensed it (globally) from Eisai. The Stenoparib DRP® is approved for ovarian cancer. It is currently being assessed for the treatment of advanced ovarian cancer in Phase II clinical trial at the Dana-Farber Cancer Institute using the Stenoparib DRP® companion diagnostic to guide patient enrollment and enhance therapeutic outcomes.

For further information, refer to the detailed report @ Advanced Ovarian Cancer Pipeline Therapeutics 

Scope of Advanced Ovarian Cancer Pipeline Drug Insight    

  • Coverage: Global 
  • Major Players: 50+ Key Players
  • Prominent Players: ImmunoGen, OncoQuest, Lee’s Pharmaceutical, Allarity Therapeutics, AstraZeneca, Jiangxi Qingfeng Pharmaceutical Co. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Ellipses Pharma, Merck KGaA, Pfizer, Jiangsu HengRui Medicine Co., Ltd., Boehringer Ingelheim, Impact Therapeutics, Inc., Glycotope, Puma Biotechnology, Inc., MaxCyte, Inc., Bayer, Xennials Therapeutics, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daiichi Sankyo, Inc., Astellas Pharma Inc, and many others.   
  • Key Drugs Profiles: 50+ Products
  • Phases:  

·       Advanced Ovarian Cancer Therapies Late-stage (Phase III)  
·       Advanced Ovarian Cancer Therapies Mid-stage (Phase II)
·       Advanced Ovarian Cancer Therapies Early-stage (Phase I) 
·       Advanced Ovarian Cancer Preclinical stage and Discovery candidates     
·       Discontinued and Inactive candidates  

  • Mechanism of Action:

·      DLL4 protein inhibitors
·      Vascular endothelial growth factor A inhibitors
·      WEE1 protein inhibitors
·      Gene transference; Interleukin 12 replacements
·      DNA topoisomerase I inhibitors; Hypoxia-inducible factor-1 alpha inhibitors
·      Tubulin polymerization inhibitors; Apoptosis stimulants

  • Molecule Types:   

·     Peptides
·     Monoclonal antibodies
·    Small molecules 
·    Polymer 
·    Gene therapy

  • Route of Administration:

·     Parenteral 
·      Intravenous
·      Oral
·       Subcutaneous
·      Topical

  • Product Types:

·       Monotherapy
·       Combination
·       Mono/Combination 

Key Questions regarding Current Advanced Ovarian Cancer Treatment Landscape and Emerging Therapies Answered in the Pipeline Report  

  • What are the current options for Advanced Ovarian Cancer treatment?
  • How many companies are developing therapies for the treatment of Advanced Ovarian Cancer? 
  • How many are Advanced Ovarian Cancer emerging therapies in the early-stage, mid-stage, and late development stages to treat Advanced Ovarian Cancer? 
  • What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and significant licensing activities that will impact the Advanced Ovarian Cancer market? 
  • Which are the dormant and discontinued products and the reasons for the same?
  • What is the unmet need for current therapies for the treatment of Advanced Ovarian Cancer?  
  • What are the current novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing Advanced Ovarian Cancer therapies? 
  • What are the critical designations that have been granted for the emerging therapies for Advanced Ovarian Cancer? 
  • How many patents are granted and pending for the emerging therapies to treat Advanced Ovarian Cancer?   

Table of Contents

1 Advanced Ovarian Cancer Report Introduction
2 Advanced Ovarian Cancer Executive Summary
3 Advanced Ovarian Cancer Overview
4 Advanced Ovarian Cancer Pipeline Therapeutics
5 Advanced Ovarian Cancer Therapeutic Assessment
6 Advanced Ovarian Cancer – DelveInsight’s Analytical Perspective In-depth Commercial Assessment
7 Advanced Ovarian Cancer Late Stage Products (Phase III)  
7.1  Mirvetuximab soravtansine (IMGN853): ImmunoGen
8 Advanced Ovarian Cancer Mid Stage Products (Phase II)
8.1  EP0057: Ellipses Pharma
9 Advanced Ovarian Cancer Early Stage Products (Phase I)  
9.1 DS-6000a: Daiichi Sankyo Company
10 Advanced Ovarian Cancer Preclinical and Discovery Stage Products
11 Advanced Ovarian Cancer Inactive Products
12 Advanced Ovarian Cancer Key Companies
13 Advanced Ovarian Cancer Key Products
14 Advanced Ovarian Cancer Unmet Needs
15 Advanced Ovarian Cancer Market Drivers and Barriers
16 Advanced Ovarian Cancer Future Perspectives and Conclusion
17 Advanced Ovarian Cancer Analyst Views
18  Appendix
19 About DelveInsight

Get a customized pipeline report @ Advanced Ovarian Cancer Drugs Pipeline Report  

Other Reports

Browse Blog Posts   

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Healthcare Consulting services comprising credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach.


Contact Us:

Shruti Thakur 

info@delveinsight.com   

+1(919)321-6187 

www.delveinsight.com 

 

Primary Logo


Source: EIN Presswire

Joaris Bella and Mike Masif Coming to Dubai Nightclub in Camden, NJ

Joaris Bella and Mike Masif performing at Dubai Nightclub in Camden, NJ

Joaris Bella and Mike Masif

Hl Production Logo

Joaris Bella and Mike Masif a power couple from Camden, NJ is coming to club Dubai to perform alongside Hip Hop Artist Maino.

CAMDEN, NJ, USA, September 20, 2021 /EINPresswire.com/ — Joaris Bella and Mike Masif are coming to Dubai Nightclub located on 2514 Federal Street in Camden to perform alongside hip hop artist Maino at the first annual "We Got UR Back" celebrity fest on October 22nd, 2021. Maino is known for hits such as “Hi Hater” in 2009 and “All the Above” ft. T-Pain in 2016 which went platinum by the end of that year. In 2015, Maino recorded “Crazy” with Erika Jayne which resulted in a number one dance hit in the USA.

Joaris Bella and Mike Masif are known for films such as “The Account" released in 2020 on Amazon Prime and "Hood Life" released free on YouTube in 2017. Both movies were written and directed by the couple. They are also the founders of UR Magazine (United Resources Magazine), a locally based magazine in which small business and artist alike can place ads and get the word out.

Things really kicked off for the power couple when they debuted a single "Money, Money" on Q102 & 98.5FM hosted by Fat Joe himself naming the artists the King and Queen of Camden. Since then they have been featured on local TV shows like 'The Plug' with Syesmind and "Ponte en Onda" with Miguel Arriaga. They have also been interviewed by LA Mega 105.7FM, Uptown Radio 98.5FM, La Supra 97.1FM, and TNT 2Real Radio Show and were issued a Certificate of Special Congressional Recognition by Congress man Donald Norcross for their outstanding and invaluable service to the community. They are currently in the works to release their first new album together entitled 'Hip2Pop' which is anticipated to drop in 2022.

“We got UR back” celebrity fest will showcase many new artists from South Jersey, Philadelphia, and Camden, including Lil Gram, Lil Mopptop, Zoeiana and Camden NJ native Mont Polk (Known as Big Dummy). In the building will be professional actor Tommy Brown, known for his roles in “Underground Kings” ft. Christopher Mann, “Creed 2,” “Lyfe Jennings Story,” “The Account” released in 2020 on Amazon Prime, and Netflix film “Jennie,” Headbanger Entertainment, Power 99FM, Holding it Down Records, Lite Seductions Entertainment and many more.

“We got your back” celebrity festival is here to bring the entertainment industry to South Jersey in a major way.

Jay Hernandez
HL Film Production
+1 724-326-3445
mikenjay@hlfilmproduction.com

Money, Money


Source: EIN Presswire

Governor Newsom Statement on Launch of U.S. Department of Housing and Urban Development Initiative, House America

Published: Sep 20, 2021

SACRAMENTO – Governor Gavin Newsom issued the following statement today after a virtual meeting with U.S. Secretary of Housing and Urban Development Marcia L. Fudge for the launch of House America, a national partnership led by the U.S. Department of Housing and Urban Development and the U.S. Interagency Council on Homelessness that brings state and local leaders together to leverage the American Rescue Plan Act to address the homelessness crisis.

“President Biden is deeply committed to tackling the housing and homelessness crisis that has plagued our nation for decades. The Biden-Harris Administration and leaders like Secretary Fudge understand that it is unacceptable to have Americans living on the street, and that we need significant investments in housing and services, along with the political will to move quickly.

“California is dedicated to doing our part toward this national goal. California has committed an unprecedented $22 billion investment for housing and homelessness as part of my California Comeback Plan, which includes additional funding from the American Rescue Plan. California will build more than 84,000 new affordable homes for Californians, including 44,000 new housing units and treatment beds for people exiting homelessness. California will account for one-third of the housing created as part of House America’s initiative to re-house at least 100,000 households experiencing homelessness.

“The American Rescue Plan also bolstered California’s ability to fund much-needed continuum of care and community services. The California Comeback Plan invests $3 billion to create 22,000 treatment beds to improve our state’s behavioral health system, which has been underfunded and overlooked for decades. In California, we’re not settling for the old way of addressing housing and homelessness – we are demanding greater accountability and more urgency to create housing and get people off the streets. We are extremely grateful to have a partner in the federal government working toward these same goals.”

###


Source: EIN Presswire